Farallon Capital Management 13F holdings, Q1 2020
Holdings as of March 31, 2020 · filings on SEC EDGAR · latest filing →
Farallon Capital Management disclosed 100 US equity positions worth $10.9bn in its Q1 2020 13F filing. The largest position was ALLERGAN PLC at 15.1% of the reported book, followed by FIS and CNC. Against the Q4 2019 filing, it opened 3 new positions, added to 30 and reduced 10 among the top 50 holdings.
What did Farallon Capital Management own in Q1 2020? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2019 |
|---|---|---|---|---|---|---|---|
| 1 | ALLERGAN PLC | 15.1% | $1.6bn | 9,300,000 | 16% | added | |
| 2 | FIS FIDELITY NATL INFORMATION SV | Technology | 5.2% | $562.1m | 4,621,208 | 33% | added |
| 3 | CNC CENTENE CORP DEL | Healthcare | 3.9% | $430.7m | 7,250,000 | – | new |
| 4 | IQV IQVIA HLDGS INC | Healthcare | 3.7% | $403.4m | 3,739,696 | 102% | added |
| 5 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 3.2% | $352.6m | 1,243,215 | 46% | added |
| 6 | GOOG ALPHABET INC | Communication Services | 3.1% | $343.2m | 295,173 | 7% | added |
| 7 | CHTR CHARTER COMMUNICATIONS INC N | Communication Services | 2.9% | $315.6m | 723,328 | 6% | added |
| 8 | IAC INTERACTIVECORP | 2.8% | $307.4m | 1,715,000 | -17% | reduced | |
| 9 | ABBV ABBVIE INC | Healthcare | 2.8% | $304.8m | 4,000,000 | 60% | added |
| 10 | WAB WABTEC | Industrials | 2.8% | $304.3m | 6,322,354 | 25% | added |
| 11 | IHS MARKIT LTD | 2.7% | $295.5m | 4,925,538 | 80% | added | |
| 12 | MSFT MICROSOFT CORP | Technology | 2.6% | $287.6m | 1,823,720 | -17% | reduced |
| 13 | V VISA INC | Financial Services | 2.6% | $284.1m | 1,763,268 | 16% | added |
| 14 | ELV ANTHEM INC | Healthcare | 2.6% | $283.8m | 1,250,000 | 0% | held |
| 15 | GD GENERAL DYNAMICS CORP | Industrials | 2.5% | $275.7m | 2,083,681 | 112% | added |
| 16 | SHW SHERWIN WILLIAMS CO | Basic Materials | 2.1% | $234.0m | 509,130 | 38% | added |
| 17 | CRM SALESFORCE COM INC | Technology | 2.1% | $232.5m | 1,614,488 | -6% | reduced |
| 18 | CI CIGNA CORP NEW | Healthcare | 2.0% | $221.5m | 1,250,000 | -17% | reduced |
| 19 | BABA ALIBABA GROUP HLDG LTD | Consumer Cyclical | 2.0% | $218.5m | 1,123,500 | -1% | reduced |
| 20 | XLRN ACCELERON PHARMA INC | 1.8% | $195.5m | 2,175,000 | 9% | added | |
| 21 | META FACEBOOK INC | Communication Services | 1.7% | $181.4m | 1,087,524 | 6% | added |
| 22 | EQIX EQUINIX INC | Real Estate | 1.6% | $176.1m | 281,933 | -32% | reduced |
| 23 | EXEL EXELIXIS INC | Healthcare | 1.6% | $172.2m | 10,000,000 | 33% | added |
| 24 | IOVA IOVANCE BIOTHERAPEUTICS INC | Healthcare | 1.6% | $172.1m | 5,750,000 | -8% | reduced |
| 25 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 1.5% | $163.3m | 1,500,000 | 3% | added |
| 26 | PANW PALO ALTO NETWORKS INC | Technology | 1.5% | $161.8m | 986,721 | -11% | reduced |
| 27 | ASND ASCENDIS PHARMA A S | Healthcare | 1.4% | $155.0m | 1,376,349 | 8% | added |
| 28 | TRU TRANSUNION | Financial Services | 1.2% | $133.9m | 2,023,887 | 32% | added |
| 29 | BRISTOL-MYERS SQUIBB CO | 1.2% | $133.8m | 35,200,000 | 16% | added | |
| 30 | QGEN QIAGEN NV | Healthcare | 1.1% | $123.2m | 2,960,986 | 37% | added |
| 31 | FORTY SEVEN INC | 1.0% | $105.4m | 1,105,000 | – | new | |
| 32 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 0.8% | $90.0m | 1,750,000 | 0% | held |
| 33 | RA PHARMACEUTICALS INC | 0.6% | $69.1m | 1,440,000 | 21% | added | |
| 34 | FATE FATE THERAPEUTICS INC | Healthcare | 0.6% | $66.6m | 3,000,000 | 33% | added |
| 35 | WRIGHT MED GROUP N V | 0.6% | $65.2m | 2,275,000 | 230% | added | |
| 36 | GRFS GRIFOLS S A | Healthcare | 0.6% | $62.7m | 3,113,222 | 0% | held |
| 37 | ZYME ZYMEWORKS INC | Healthcare | 0.6% | $62.1m | 1,750,000 | 3% | added |
| 38 | ZOGENIX INC | 0.5% | $55.6m | 2,250,000 | 29% | added | |
| 39 | FIBROGEN INC | 0.5% | $55.6m | 1,599,667 | 18% | added | |
| 40 | BROADMARK RLTY CAP INC | 0.5% | $53.9m | 7,170,213 | -0% | held | |
| 41 | APELLIS PHARMACEUTICALS INC | 0.5% | $53.6m | 2,000,000 | 300% | added | |
| 42 | PLAYA HOTELS & RESORTS NV | 0.5% | $53.6m | 30,606,930 | 0% | held | |
| 43 | KARYOPHARM THERAPEUTICS INC | 0.5% | $49.5m | 35,102,000 | 46% | added | |
| 44 | MIRATI THERAPEUTICS INC | 0.4% | $46.1m | 600,000 | 243% | added | |
| 45 | EFX EQUIFAX INC | Industrials | 0.4% | $45.2m | 378,275 | -42% | reduced |
| 46 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 0.4% | $44.4m | 1,250,000 | 0% | held |
| 47 | PTC THERAPEUTICS INC | 0.4% | $42.6m | 39,676,000 | 0% | held | |
| 48 | DECIPHERA PHARMACEUTICALS IN | 0.4% | $41.2m | 1,000,000 | 5% | added | |
| 49 | KARUNA THERAPEUTICS INC | 0.4% | $40.8m | 567,047 | -5% | reduced | |
| 50 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 0.3% | $34.6m | 365,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.